ResearcherPurdue University West LafayetteNo recent work listed

Tony Hazbun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0675-8093; OpenAlex author ID A5045904567; NIH RePORTER profile ID 8743934. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2012: 1 grant · 2013: 1 paper

Papers 1

Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-12-0632 ↗

Grants 1

Integrated Genomewide Analysis of the lpL1 Kinase Signaling Network R01GM087461 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bing Song · 1 shared paper, 2013 · strength 0.03
- Paper Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. DOI 10.1158/1535-7163.mct-12-0632 ↗
Xiaoqi Liu · 1 shared paper, 2013 · strength 0.03
- Paper Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. DOI 10.1158/1535-7163.mct-12-0632 ↗
Stephen F Konieczny · 1 shared paper, 2013 · strength 0.03
- Paper Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. DOI 10.1158/1535-7163.mct-12-0632 ↗
Elena Gabriela Chiorean · 1 shared paper, 2013 · strength 0.03
- Paper Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. DOI 10.1158/1535-7163.mct-12-0632 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.